Document is current
Any future updates will be listed below
-
Authors
Heath, Bryony
Kaira, Bubacarr G.
Thakker, Dhruma
Mohammed, Omar J.
Choudhury, Ruhul
Dave, Foram
Vaghela, Poonam
Dubinina, Elena
Parsons, Tina
Durrant, Lindy
Vankemmelbeke, Mireille https://orcid.org/0000-0002-8100-813X
- License Information
-
More Information
Article History
Received: 13 June 2025
Accepted: 24 July 2025
First Online: 19 August 2025
Declarations
:
: Animal studies complied with the UK Animals Scientific Procedures Act 1986 (ASPA) and were carried out in concordance with Crown Bioscience’s UK Guidelines and Standard Operating Procedures. Patient-derived tumor material was sourced from Crown Bioscience International and was acquired after approval by the IntegReview Ethical Review Board. Patient SCLC tissues were acquired through AccioBiobank, BioMedica CRO and Indivdumed GmbH, according to local institutional review board (IRB) approval and with Informed Consent (IC). Human leukocytes were obtained by BioIVT under IRB approved protocols. All donors signed IC forms.
: Not applicable.
: LD has ownership interest in a patent. LD is a director and shareholder in Scancell Ltd. All other authors are employees of Scancell Ltd.
